WHO Solidarity trial finds Remdesivir has no substantial effect on mortality in COVID-19 patients

The results of the Solidarity trial conducted on 11,266 hospitalised patients in 30 countries found remdesivir, along with three other repurposed drugs hydroxychloroquine, lopinavir/ritonavir and interferon to have little or no effect on 28-day mortality.

from Moneycontrol Latest News https://ift.tt/3lSjvsQ